Newsroom

Literature

Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)

SITC 2023
Presented
Nov 3, 2023
Type
Poster

Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system

Breast Cancer Research and Treatment
Presented
Oct 17, 2023
Type
Publication

Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study

ASCO 2023
Presented
Jun 3, 2023
Type
Poster

LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer

ASCO 2023
Presented
Jun 3, 2023
Type
Poster

A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

ASCO 2023
Presented
Jun 2, 2023
Type
Poster

Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial

ASCO 2023
Presented
Jun 2, 2023
Type
Abstract

Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

ASCO 2023
Presented
Jun 2, 2023
Type
Poster

Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer

ASCO 2023
Presented
Jun 2, 2023
Type
Poster

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients